Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hemangiosarcoma × avelumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 11 Urinary Bladder Neoplasms 9 Neoplasms 8 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Carcinoma, Renal Cell 5 Pancreatic Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Merkel Cell 4 Breast Neoplasms 4 Lymphoma 3 Fallopian Tube Neoplasms 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Kidney Diseases 2 Colorectal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Urothelial Cancer 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Turcot syndrome 1 Stomach Neoplasms 1 Sezary Syndrome 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

pazopanib 5 Doxorubicin 3 carotuximab 2 Sorafenib 2 Radiotherapy, Conformal 2 Gemcitabine 2 tremelimumab 1 trebananib 1 temsirolimus 1 romidepsin 1 indolepropanol phosphate 1 eribulin 1 durvalumab 1 cixutumumab 1 Watchful Waiting 1 TTI-621 1 Sunitinib 1 Sirolimus 1 Razoxane 1 Paclitaxel 1 Observation 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 HhAntag691 1 Fluorodeoxyglucose F18 1 Docetaxel 1 Dexrazoxane 1 Cyproheptadine 1 Bevacizumab 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡